ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is immunohistochemically characterized by a lack of human epidermal growth factor receptor 2 (also defined by a lack of HER2 amplification by FISH), and oestrogen receptor and progesterone receptors expression [2].